AP01 has completed a phase 1b trial (ATLAS) in idiopathic pulmonary fibrosis (IPF) and has started an open-label extension in ...

While positive, for rare disease it represents the first step of a much longer journey – one that will determine whether ...

That's the finding of an independent report published today by the Nuffield Trust, funded by the Association of the British ...

At the LSX World Congress in Lisbon this year, web editor Nicole Raleigh spoke with Roi Raz, CEO of ReBio Pharma, a preclinical stage biotechnology company that has developed SiSu, an injectable, ...

AbbVie has opened a new front in the pharma industry's battle to change the 340B drug discounting programme for safety net ...

The conflict in the Middle East is sending shockwaves through the global economy and disrupting global trade.

The 23andMe Research Institute said that some people lose less than 5% with GLP-1 drugs, while others can lose 20% or more, ...

The Beijing biotech has been set up to tap into the growing interest in macrocyclic peptides as an emerging treatment ...

Chief among its criticisms is Novavax's failure to build sales of its protein-based COVID-19 vaccine Nuvaxovid/Covovax, a ...

Preserve study integrity. Resist the temptation to bolt new exploratory endpoints midstream. If an additional endpoint is ...

France-based investment group Jeito Capital has closed its second fund, raking in €1 billion ($1.2 billion), which it claims ...

In modern drug discovery, successfully navigating the progress from molecular concept to viable therapeutic often hinges on ...